Login / Signup

Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.

Aristeidis ChaidosAlexia KatsarouChira MustafaDragana MilojkovicAnastasios Karadimitris
Published in: British journal of haematology (2020)
Keyphrases
  • multiple myeloma
  • coronavirus disease
  • sars cov
  • early onset
  • combination therapy
  • respiratory syndrome coronavirus
  • drug induced